CSPIA
RCEL icon

Cary Street Partners Investment Advisory’s Avita Medical RCEL Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-775
Closed -$11.3K – 1535
2023
Q3 		$11.3K Hold
775
– – ﹤0.01% 1266
2023
Q2 		$13.2K Hold
775
– – ﹤0.01% 1169
2023
Q1 		$10.8K Hold
775
– – ﹤0.01% 1128
2022
Q4 		$5.12K Buy
+775
New +$4.64K ﹤0.01% 1322

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cary Street Partners Investment Advisory's RCEL Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 775 shares — an estimated $11.3K sold.

Cary Street Partners Investment Advisory first reported a position in RCEL in Q4 2022 and held it in 4 quarters. The position peaked at $13.2K in Q2 2023. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 775 Avita Medical shares in Q4 2023, an estimated $11.3K.
  • Cary Street Partners Investment Advisory first reported a position in Avita Medical in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Avita Medical position peaked at $13.2K in Q2 2023.
  • 84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.